Diabetes
Inhaled Insulin
An experimental insulin delivery method being tested at City of
Hope may offer millions of people with diabetes a new option for
treatment besides insulin injections. A 12-month clinical trial led
by principal investigator Wei Fung, MD, is underway at the Leslie
and Susan Gonda (Goldshmied) Diabetes and Genetic Research Center to
test the alternative: an inhalant that delivers a dry-powdered
insulin to the patient’s lungs. During the trial, patients will
report on such quality-of-life issues as the ease of using an
inhalant instead of injections. When the patient is ready to use
insulin, they insert a package containing the correct dosage into an
inhaler and administer the medication. The use of an inhaled insulin
delivery system could provide a freedom that may prove invaluable to
people with diabetes.
More
about diabetes
Back to
Med/Sci Information Index
|
